These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6092740)

  • 1. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
    Arai S; Kobayashi S; Hayashi S
    Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
    Takahashi C; Miyazawa K
    Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cefodizime to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch.
    Arai S; Masuyoshi S; Fujimoto K
    Arzneimittelforschung; 1987 Apr; 37(4):441-4. PubMed ID: 3606699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 May; 37(5):791-801. PubMed ID: 6090721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of clinical isolates to aztreonam].
    Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
    Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial activity of cefodizime against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K
    Jpn J Antibiot; 1993 Oct; 46(10):860-76. PubMed ID: 8254888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental and clinical studies on ceftizoxime in pediatric field (author's transl)].
    Iwai N; Taneda Y; Sasaki A; Inokuma K; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Jan; 35(1):47-68. PubMed ID: 6279913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
    Kumasaka Y; Nakahata H; Hirai Y; Imamura K; Takebe K; Suzuki I; Senda H
    Jpn J Antibiot; 1986 Jan; 39(1):154-8. PubMed ID: 3517405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
    Heymès R; Lutz A; Schrinner E
    Infection; 1977; 5(4):259-60. PubMed ID: 413795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.